885 related articles for article (PubMed ID: 30675818)
21. Integration of care for HIV and opioid use disorder.
Oldfield BJ; Muñoz N; McGovern MP; Funaro M; Villanueva M; Tetrault JM; Edelman EJ
AIDS; 2019 Apr; 33(5):873-884. PubMed ID: 30882491
[TBL] [Abstract][Full Text] [Related]
22. Criminal justice continuum for opioid users at risk of overdose.
Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
[TBL] [Abstract][Full Text] [Related]
23. Treatment of opioid use disorder in primary care.
Buresh M; Stern R; Rastegar D
BMJ; 2021 May; 373():n784. PubMed ID: 34011512
[TBL] [Abstract][Full Text] [Related]
24. Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.
Andraka-Christou B
Health Aff (Millwood); 2021 Jun; 40(6):920-927. PubMed ID: 34097509
[TBL] [Abstract][Full Text] [Related]
25. The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
Chandler RK; Finger MS; Farabee D; Schwartz RP; Condon T; Dunlap LJ; Zarkin GA; McCollister K; McDonald RD; Laska E; Bennett D; Kelly SM; Hillhouse M; Mitchell SG; O'Grady KE; Lee JD
Contemp Clin Trials; 2016 May; 48():166-72. PubMed ID: 27180088
[TBL] [Abstract][Full Text] [Related]
26. Common elements in opioid use disorder guidelines for buprenorphine prescribing.
Atkinson TJ; Pisansky AJB; Miller KL; Yong RJ
Am J Manag Care; 2019 Mar; 25(3):e88-e97. PubMed ID: 30875177
[TBL] [Abstract][Full Text] [Related]
27. The Opioid Epidemic: Challenge to Military Medicine and National Security.
Dembek ZF; Chekol T; Wu A
Mil Med; 2020 Jun; 185(5-6):e662-e667. PubMed ID: 32077961
[TBL] [Abstract][Full Text] [Related]
28. Opioid Use Disorder and Overdose in the First Year Postpartum: A Rapid Scoping Review and Implications for Future Research.
Frankeberger J; Jarlenski M; Krans EE; Coulter RWS; Mair C
Matern Child Health J; 2023 Jul; 27(7):1140-1155. PubMed ID: 36840785
[TBL] [Abstract][Full Text] [Related]
29. Comparing Canadian and United States opioid agonist therapy policies.
Priest KC; Gorfinkel L; Klimas J; Jones AA; Fairbairn N; McCarty D
Int J Drug Policy; 2019 Dec; 74():257-265. PubMed ID: 30765118
[TBL] [Abstract][Full Text] [Related]
30. Responding to the US opioid crisis: leveraging analytics to support decision making.
Brandeau ML
Health Care Manag Sci; 2023 Dec; 26(4):599-603. PubMed ID: 37804456
[TBL] [Abstract][Full Text] [Related]
31. Opioid use disorder treatment for people experiencing homelessness: A scoping review.
McLaughlin MF; Li R; Carrero ND; Bain PA; Chatterjee A
Drug Alcohol Depend; 2021 Jul; 224():108717. PubMed ID: 33985863
[TBL] [Abstract][Full Text] [Related]
32. Mobile service delivery in response to the opioid epidemic in Philadelphia.
Stewart RE; Christian HP; Cardamone NC; Abrams C; Drob C; Mandell DS; Metzger D; Lowenstein M
Addict Sci Clin Pract; 2023 Nov; 18(1):71. PubMed ID: 38031174
[TBL] [Abstract][Full Text] [Related]
33. Quantifying opioid use disorder Cascade of Care outcomes in an American Indian tribal nation in Minnesota.
Boyd T; Stipek J; Kraft A; Muskrat J; Hallgren KA; Alexander C; Greenfield B
Drug Alcohol Depend; 2021 May; 222():108661. PubMed ID: 33775445
[TBL] [Abstract][Full Text] [Related]
34. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA
J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410
[TBL] [Abstract][Full Text] [Related]
35. Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States.
Davis CS; Carr DH
Int J Drug Policy; 2019 Nov; 73():42-48. PubMed ID: 31336293
[TBL] [Abstract][Full Text] [Related]
36. Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder.
Hughto JMW; Moyo P; Green TC
J Addict Med; 2022 Nov-Dec 01; 16(6):616-618. PubMed ID: 35245915
[TBL] [Abstract][Full Text] [Related]
37. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
Chhatwal J; Mueller PP; Chen Q; Kulkarni N; Adee M; Zarkin G; LaRochelle MR; Knudsen AB; Barbosa C
JAMA Netw Open; 2023 Jun; 6(6):e2314925. PubMed ID: 37294571
[TBL] [Abstract][Full Text] [Related]
38. Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus.
Rush AJ; Gore-Langton RE; Bart G; Bradley KA; Campbell CI; McKay J; Oslin DW; Saxon AJ; Winhusen TJ; Wu LT; Moran LM; Tai B
Addict Sci Clin Pract; 2024 Feb; 19(1):14. PubMed ID: 38419116
[TBL] [Abstract][Full Text] [Related]
39. The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.
Banta-Green CJ; Owens MD; Williams JR; Sears JM; Floyd AS; Williams-Gilbert W; Kingston S
Addict Sci Clin Pract; 2022 Jul; 17(1):34. PubMed ID: 35799210
[TBL] [Abstract][Full Text] [Related]
40. Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic.
Kennalley AL; Fanelli JL; Furst JA; Mynarski NJ; Jarvis MA; Nichols SD; McCall KL; Piper BJ
BMJ Open; 2023 Nov; 13(11):e074845. PubMed ID: 37973543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
